Comparison between D.S.Kulkarni Developers FPO and Plethico Pharmaceuticals IPO.
D.S.Kulkarni Developers FPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| D.S.Kulkarni Developers FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | Mainboard | Mainboard |
| Issue Type | FPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Indian Overseas Bank A.K.Capital Services Ltd. | |
| Registrar | Sharepro Services Pvt.Ltd. | |
| Market Maker | ||
| DRHP | DRHP  | |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of D.S.Kulkarni Developers FPO is up to ₹133.67 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of D.S.Kulkarni Developers FPO is ₹275.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.
| D.S.Kulkarni Developers FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹250.00 per share | ₹280.00 per share |
| Issue Price (Upper) | ₹275.00 per share | ₹300.00 per share |
| Issue Price (Final) | ₹275.00 per share | ₹300.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 48,60,853 shares | 36,66,667 shares |
| Fresh Issue Size (Amount) | up to ₹133.67 Cr | up to ₹110.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 48,60,853 shares | 36,66,667 shares |
| Issue Size Total (Amount) | up to ₹133.67 Cr | up to ₹110.00 Cr |
D.S.Kulkarni Developers FPO opens on Apr 25, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of D.S.Kulkarni Developers FPO and Plethico Pharmaceuticals IPO is May 03, 2006, and Apr 17, 2006, respectively.
D.S.Kulkarni Developers FPO P/E ratio is 82.88, as compared to Plethico Pharmaceuticals IPO P/E ratio of .
| D.S.Kulkarni Developers FPO | Plethico Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| |||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 24.18 | 97.5 | ||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 21.05 | 87.01 | ||||||||||||||||||||||||||||||||
| P/E Ratio | 82.88 | |||||||||||||||||||||||||||||||||
| Market Cap | ₹453.78 Cr. | ₹1022.00 Cr. | ||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||
| EPS | ₹3.32 | |||||||||||||||||||||||||||||||||
| RoNW | 16.82% | |||||||||||||||||||||||||||||||||
In the D.S.Kulkarni Developers FPO Retail Individual Investors (RII) are offered 16,62,445 shares while in Plethico Pharmaceuticals IPO retail investors are offered 16,62,445 shares. Qualified Institutional Buyers (QIB) are offered 23,74,923 shares in D.S.Kulkarni Developers FPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.
| D.S.Kulkarni Developers FPO | Plethico Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 23,74,923 shares | 22,00,000 shares |
| NII | 7,12,477 shares | 3,66,667 shares |
| RII | 16,62,445 shares | 11,00,000 shares |
| Employee | 1,10,000 shares | 0 shares |
| Others | ||
| Total | 48,59,845 shares | 36,66,667 shares |
D.S.Kulkarni Developers FPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .
